Category Archives: Healthcare

Maxim Group Keeps Their Buy Rating on Agile Therapeutics (AGRX)

Maxim Group analyst Jason McCarthy maintained a Buy rating on Agile Therapeutics (AGRX – Research Report) yesterday and set a price target of $3. The company’s shares opened today at $1.33. McCarthy observed: “Agile announced that the FDA has accepted

H.C. Wainwright Believes Iovance Biotherapeutics Inc (NASDAQ: IOVA) Won’t Stop Here

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Iovance Biotherapeutics Inc (IOVA – Research Report), with a price target of $26. The company’s shares closed yesterday at $16.63, close to its 52-week high

Analysts Offer Insights on Healthcare Companies: PAVmed Inc (NASDAQ: PAVM) and Aurinia Pharmaceuticals (NASDAQ: AUPH)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PAVmed Inc (PAVM – Research Report) and Aurinia Pharmaceuticals (AUPH – Research Report) with bullish sentiments. PAVmed Inc (PAVM) In a report

Wednesday’s Midday Movers: EKSO BIONICS (EKSO), Medical Marijuana Inc (MJNA), ImmunoCellular Therapeutics (IMUC), Can-Fite BioPharma (CANF), Whiting Petroleum Corp (WLL)

So far Wednesday, May 22, NASDAQ is down -0.03% and the S&P is down -0.08%. Here are this morning’s most active stocks: EKSO BIONICS (EKSO – Research Report), Medical Marijuana Inc (MJNA – Research Report), ImmunoCellular Therapeutics (IMUC – Research

Wednesday’s Highlights at Noon: EKSO BIONICS (EKSO), Cytori Therapeutics Inc (CYTX), Medical Marijuana Inc (MJNA), Can-Fite BioPharma (CANF), ImmunoCellular Therapeutics (IMUC)

So far Wednesday, May 22, NASDAQ is down -0.03% and the S&P is down -0.07%. Here are this morning’s most active stocks: EKSO BIONICS (EKSO – Research Report), Cytori Therapeutics Inc (CYTX – Research Report), Medical Marijuana Inc (MJNA –

A Director at Bellerophon (NASDAQ: BLPH) is Buying Shares

Today, a Director at Bellerophon (BLPH – Research Report), Jonathan Peacock, bought shares of BLPH for $12K. In addition to Jonathan Peacock, 2 other BLPH executives reported Buy trades in the last month. This recent transaction increases Jonathan Peacock’s holding